QCG
CLLS

Quadrant Capital Group’s Cellectis CLLS Stock Holding History

Quadrant Capital Group’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-944
Closed -$2.99K – 1505
2026
Q1 		$2.99K Sell
944
-1,817
-66% -$6.96K ﹤0.01% 2450
2025
Q4 		$13.4K Buy
+2,761
New +$11.5K ﹤0.01% 2125
2022
Q2 		– Sell
-1,036
Closed -$5K – 2563
2022
Q1 		$5K Sell
1,036
-832
-45% -$4.58K ﹤0.01% 1896
2021
Q4 		$15K Buy
1,868
+926
+98% +$9.1K ﹤0.01% 1426
2021
Q3 		$12K Buy
942
+248
+36% +$3.44K ﹤0.01% 1479
2021
Q2 		$11K Buy
+694
New +$11.7K ﹤0.01% 1501
2020
Q1 		– Sell
-361
Closed -$6K – 2129
2019
Q4 		$6K Buy
+361
New +$4.82K ﹤0.01% 2033

Other funds holding CLLS

BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Quadrant Capital Group's CLLS Position: Q2 2026 in Review

Quadrant Capital Group sold out of Cellectis (CLLS) in Q2 2026, closing a stake of 944 shares — an estimated $2.99K sold.

Quadrant Capital Group first reported a position in CLLS in Q4 2019 and held it in 7 quarters. The position peaked at $15K in Q4 2021. 27 funds tracked by Wall St. Rank hold CLLS as of Q2 2026.

  • Quadrant Capital Group reported no remaining Cellectis position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 944 Cellectis shares in Q2 2026, an estimated $2.99K.
  • Quadrant Capital Group first reported a position in Cellectis in Q4 2019 and held it in 7 quarters.
  • Quadrant Capital Group's Cellectis position peaked at $15K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held Cellectis as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.